We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, June 28th:
InsightEnterprises, Inc. (NSIT - Free Report) : This IT services provider has a Zacks Rank #1 (Strong Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 10.6% over the last 60 days.
Iconix Brand Group, Inc. (ICON - Free Report) : This brand management company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings advancing 14.3% over the last 60 days.
Nutrisystem, Inc. : This weight management services provider has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Value Stocks to Buy for June 28th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, June 28th:
InsightEnterprises, Inc. (NSIT - Free Report) : This IT services provider has a Zacks Rank #1 (Strong Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 10.6% over the last 60 days.
Insight Enterprises, Inc. Price and Consensus
Insight Enterprises, Inc. price-consensus-chart | Insight Enterprises, Inc. Quote
InsightEnterprises has a price-to-earnings ratio (P/E) of 11.20 compared with 18.50 for the industry. The company possesses a Value Score of A.
Insight Enterprises, Inc. PE Ratio (TTM)
Insight Enterprises, Inc. pe-ratio-ttm | Insight Enterprises, Inc. Quote
Iconix Brand Group, Inc. (ICON - Free Report) : This brand management company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings advancing 14.3% over the last 60 days.
Iconix Brand Group, Inc. Price and Consensus
Iconix Brand Group, Inc. price-consensus-chart | Iconix Brand Group, Inc. Quote
Iconix Brand has a price-to-earnings ratio (P/E) of 1.51, compared with 16.60 for the industry. The company possesses a Value Score of A.
Iconix Brand Group, Inc. PE Ratio (TTM)
Iconix Brand Group, Inc. pe-ratio-ttm | Iconix Brand Group, Inc. Quote
Nutrisystem, Inc. : This weight management services provider has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
NutriSystem Inc Price and Consensus
NutriSystem Inc price-consensus-chart | NutriSystem Inc Quote
Nutrisystem has a price-to-earnings ratio (P/E) of 17.96, compared with 18.50 for the industry. The company possesses a Value Score of A.
NutriSystem Inc PE Ratio (TTM)
NutriSystem Inc pe-ratio-ttm | NutriSystem Inc Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>